
Judith A. Waltz
Articles
-
Nov 6, 2024 |
mondaq.com | Judith A. Waltz |Daniel Costandy
On Friday, November 1, 2024, the Center for Medicare & Medicaid Services (CMS) issued the display copy of the final rule interpreting the 60-day Refund Rule for Medicare Parts A/B (Traditional Medicare) and C/D (Medicare Advantage (MA) and the Prescription Drug Plans) established by the Affordable Care Act (Final Rule). The Final Rule will be published in the Federal Register on December 9, 2024, with an effective date of January 1, 2025.
-
Nov 5, 2024 |
jdsupra.com | Daniel Costandy |Judith A. Waltz
On Friday, November 1, 2024, the Center for Medicare & Medicaid Services (CMS) issued the display copy of the final rule interpreting the 60-day Refund Rule for Medicare Parts A/B (Traditional Medicare) and C/D (Medicare Advantage (MA) and the Prescription Drug Plans) established by the Affordable Care Act (Final Rule). The Final Rule will be published in the Federal Register on December 9, 2024, with an effective date of January 1, 2025.
-
Nov 4, 2024 |
natlawreview.com | Judith A. Waltz
On Friday, November 1, 2024, the Center for Medicare & Medicaid Services (CMS) issued the display copy of the final rule interpreting the 60-day Refund Rule for Medicare Parts A/B (Traditional Medicare) and C/D (Medicare Advantage (MA) and the Prescription Drug Plans) established by the Affordable Care Act (Final Rule). The Final Rule will be published in the Federal Register on December 9, 2024, with an effective date of January 1, 2025.
-
Oct 15, 2024 |
jdsupra.com | Jessica M. Boubker |Kyle Faget |Judith A. Waltz
The Centers for Medicare & Medicaid Services (CMS) released a Final Notice for Transitional Coverage for Emerging Technologies (TCET), effective August 12, 2024, to provide “transparent, predictable, and expedited national coverage” for eligible devices designated as “breakthrough devices” by the U.S. Food & Drug Administration (FDA).
-
Sep 3, 2024 |
today.westlaw.com | Daniel Costandy |Judith A. Waltz |Lisa M. Noller
Enter to open, tab to navigate, enter to select
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →